A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.
Learn how Organ-on-a-Chip technology supports human-relevant preclinical research and how Liver-Chip models can improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results